The efficacy of steroid therapy in the patient with Fukuyama congenital muscular dystrophy

Not Applicable

• Conditions: Fukuyama congenital muscular dystrophy

• Registration Number: JPRN-UMIN000020715
• Lead Sponsor: The department of Pediatrics, Tokyo Women's Medical University

Brief Summary

Not available

Detailed Description

Not available

Study Timeline

• Results First Posted: 1900-01-01
• Study Start: 2016-02-01
• Study Completion: 2019-03-31
• Last Update Posted: 17 October 2023

Recruitment & Eligibility

• Status: Complete: follow-up complete
• Sex: All
• Target Recruitment: 10

Inclusion Criteria

Not provided

Exclusion Criteria

1. Patients with infections without effective antibacterial agents or patients with systemic fungal disease [Infections may be aggravated because of immunosuppression.] 2. Patients with peptic ulcer [Peptic ulcer may be aggravated because of a reduction in the function of gastric mucosal barrier.] 3. Patients with psychosis [Psychosis may be aggravated because of a possible effect on central nervous system.] 4. Patients with tuberculous disease [Tuberculous disease may be aggravated because of immunosuppression.] 5. Patients with herpes simplex keratitis [Herpes simplex keratitis may be aggravated because of immunosuppression.] 6. Patients with posterior capsular cataract [Posterior capsular cataract may be aggravated because of a possible effect on the lens fibers.] 7. Patients with glaucoma [Glaucoma may be aggravated because of an increase in intraocular pressure.] 8. Patients with hypertension [Hypertension may be aggravated because of retention of sodium and water.] 9. Patients with electrolyte abnormality [Electrolyte abnormality may be aggravated because of retention of sodium and water.] 10. Patients with thrombosis [Thrombosis may be aggravated because of increased blood clotting.] 11. Patients with the unhealed surgical wound of the viscus [Wound healing may be delayed.] 12. Patients with a history of acute myocardial infarction [Cardiac rupture has been reported to occur.] 13. Patients who has been determined to be inappropriate as a subject by principal investigator.

Study & Design

• Study Type: Interventional
• Study Design: Not specified